Cargando…
Cell-Mimicking Nanodecoys Neutralize SARS-CoV-2 and Mitigate Lung Injury in a Nonhuman Primate Model of COVID-19
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has grown into a global pandemic, and no specific antiviral treatments have been approved to date. The angiotensin-converting enzyme 2 (ACE2) plays a fundamental role in SARS-CoV-2 pathogenes...
Autores principales: | Li, Zhenhua, Wang, Zhenzhen, Dinh, Phuong-Uyen C., Zhu, Dashuai, Popowski, Kristen D., Lutz, Halle, Hu, Shiqi, Lewis, Mark G., Cook, Anthony, Andersen, Hanne, Greenhouse, Jack, Pessaint, Laurent, Lobo, Leonard J., Cheng, Ke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364483/ https://www.ncbi.nlm.nih.gov/pubmed/34140674 http://dx.doi.org/10.1038/s41565-021-00923-2 |
Ejemplares similares
-
Exosome therapeutics for lung regenerative medicine
por: Popowski, Kristen, et al.
Publicado: (2020) -
Advanced Nanobiomedical Approaches to Combat Coronavirus Disease of 2019
por: Lutz, Halle, et al.
Publicado: (2021) -
A SARS-CoV-2 and influenza double hit vaccine based on RBD-conjugated inactivated influenza A virus
por: Wang, Zhenzhen, et al.
Publicado: (2023) -
Exosome therapeutics for COVID‐19 and respiratory viruses
por: Popowski, Kristen D., et al.
Publicado: (2021) -
Bispecific Antibody Inhalation Therapy for Redirecting Stem Cells from the Lungs to Repair Heart Injury
por: Liu, Mengrui, et al.
Publicado: (2020)